Position in ETON
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,673,269
+$4,217,244 QoQ
Shares Held
322,466
+6.7% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 163 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. ETON ranks #12 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,415,471 | $101,715,746 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
260,605 | $43,922,366 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
2,649,866 | $38,396,558 | |
| 4 | ALKS |
Alkermes plc.
|
655,140 | $34,329,336 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
300,967 | $33,389,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
58,580 | $31,740,401 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,180,709 | $29,057,248 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
437,192 | $27,958,428 |
All Filings in ETON
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,673,269 | 322,466 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,456,025 | 302,108 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,691,814 | 277,458 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,993,336 | 229,790 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,249,668 | 87,696 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $510,334 | 39,317 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,662 | 350 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,100 | 350 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,151 | 350 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,312 | 350 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,533 | 350 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,459 | 350 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,221 | 350 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,347 | 350 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $987 | 350 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $735 | 350 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $917 | 350 | Shares | Defined | 2022-08-12 | |
| 2021-12-31 | $3,037 | 708 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,855 | 765 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $10,059 | 1,633 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $15,803 | 2,159 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $23,959 | 2,947 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $24,869 | 3,148 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $3,008 | 552 | Shares | Defined | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||